Evidence map›Paper›PMID 39568286›Full record

ArticleNeurogastroenterology and motility2025

Perceptions and Practices of Primary Care Providers in Europe and the US in the Diagnosis and Treatment of Irritable Bowel Syndrome: A Multinational Survey.

Joel J Heidelbaugh, A Pali Hungin, Olafur S Palsson, Foteini Anastasiou, Lars Agreus, Pierluigi Fracasso, Heidi-Ingrid Maaroos, Jalena Rakik Matic, Juan M Mendive, Bohumil Seifert and 1 more

Abstract read
In one paragraph

Article in Neurogastroenterology and motility, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Diagnosis and treatment of irritable bowel syndrome with diarrhea: Key clinical considerations.Journal of the American Association of Nurse Practitioners · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Joel J HeidelbaughDepartment of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.
A Pali HunginPrimary Care and General Practice, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Olafur S PalssonDivision of Gastroenterology and Hepatology, Center for Functional Gastrointestinal and Motility Disorders, University of North Carolina, Chapel Hill, North Carolina, USA.ORCID https://orcid.org/0000-0002-4480-3708
Foteini Anastasiou4th Local Primary Care Team (TOMY), Municipality Practice, Academic Practice of Heraklion, Crete, Greece.
Lars AgreusDivision of Family Medicine and Primary Care, Karolinska Institutet, Stockholm, Sweden.
Pierluigi FracassoItalian Group for Primary Care Gastroenterology, Rome, Italy.
Heidi-Ingrid MaaroosFaculty of Medicine, University of Tartu, Tartu, Estonia.
Jalena Rakik MaticHealth Center Zagreb West, Family Medicine Practice, Zagreb, Croatia.
Juan M MendiveLa Mina Primary Health Care Academic Centre, Catalan Health Institute (ICS), training Unit of Family Medicine, University of Barcelona, Barcelona, Spain.
Bohumil SeifertInstitute of General Practice, First Faculty of Medicine, Charles University, Prague, Czech Republic.
Douglas A DrossmanCenter for Education and Practice of Biopsychosocial Care, Drossman Gastroenterology, Center for Functional Gastrointestinal and Motility Disorders at the University of North Carolina, hapel Hill, North Carolina, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe knowledge and proficiency of primary care practitioners (PCPs) in diagnosing and managing irritable bowel syndrome (IBS) remain generally low and variable internationally. This variability is partly due to a lack of familiarity with the Rome Foundation diagnostic criteria and treatment guidelines for this condition.

methodsWe conducted an electronic survey of PCPs in the United States and nine European countries to assess their understanding of IBS pathophysiology; the use of Rome IV criteria in diagnosis, knowledge of and frequency in prescribing various recommended treatments; and the likelihood of referring patients with suspected IBS to subspecialists.

resultsMost PCPs in the United States and Europe perceive IBS as a diagnosis of exclusion rather than a definitive diagnosis. They also believe IBS is underdiagnosed in primary care and challenging to diagnose confidently. The majority of PCPs consider diet as a crucial component of IBS management. Notably, US PCPs reported greater confidence than their European counterparts in recommending dietary interventions such as increased dietary fiber, a low FODMAP diet, and gluten restriction. Conversely, both groups exhibited moderate to high confidence in recommending over-the-counter treatments. European PCPs showed greater confidence in treating IBS with antispasmodics and secretagogues, while US PCPs expressed greater confidence in prescribing neuromodulators. Additionally, US PCPs were more likely to refer patients with suspected IBS to a gastroenterologist, whereas both US and European PCPs showed similar referral patterns to dietitians and referred very few patients to mental health providers. Both US and European PCPs reported that IBS is moderately to extremely difficult to treat effectively and emphasized the importance of a strong and longitudinal doctor-patient relationship in managing the condition.

conclusionDespite the Rome Foundation recommendations and criteria to support a positive diagnosis of IBS, most PCPs still rely on exclusionary investigations such as endoscopy and a serologic workup, while a significant percentage suggest referring patients to gastroenterologists.

Indexed as

Attitude of Health PersonnelIrritable Bowel SyndromePhysicians, Primary CarePractice Patterns, Physicians'Primary Health CareAdultEuropeFemaleHumansMaleSurveys and QuestionnairesUnited Statesdiagnosisdisorders of gut‐brain interaction (DGBI)epidemiologyfunctional gastrointestinal disorders (FGID)irritable bowel syndrome (IBS)primary caretreatment

Identifiers

PMID39568286
PMCPMC11748826

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.